Supernus Pharmaceuticals (SUPN) To Host Fourth Quarter And Full Year 2013 Earnings Conference Call
2/25/2014 7:54:15 AM
Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, today announced that the Company expects to report fourth quarter and full year 2013 financial results after the market closes Wednesday, March 12, 2014. CEO, Jack Khattar, and CFO, Greg Patrick, will be hosting a conference call on Thursday, March 13, 2014 at 9:00 AM Eastern Time, to discuss 2013 financial results and to provide a business update.
Help employers find you! Check out all the jobs and post your resume.
comments powered by